Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13879)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 8, 2015 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hong YP, Li ZD, Prasoon P, Zhang Q. Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. World J Hepatol 2015; 7(7): 980-992 [PMID: 25954480 DOI: 10.4254/wjh.v7.i7.980] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i7/980.htm |
| Number | Citing Articles |
| 1 |
Liang Li, Hongyang Wang. Heterogeneity of liver cancer and personalized therapy. Cancer Letters 2016; 379(2): 191 doi: 10.1016/j.canlet.2015.07.018
|
| 2 |
Wei Zhang, Bixiang Zhang, Xiao-ping Chen. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma. Frontiers of Medicine 2021; 15(2): 155 doi: 10.1007/s11684-021-0848-3
|
| 3 |
Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, Giovanni Galati, Giuseppe Lombardi, GianCarlo Mazza, Luca Marzi, Carlo Saitta, Jean-Charles Nault, Rodolfo Sacco. The calm before the storm: a report from the International Liver Cancer Association Congress 2015 – part 2. Future Oncology 2016; 12(3): 285 doi: 10.2217/fon.15.324
|
| 4 |
Zejian Huang, Ning Zhang, Wenda Li, Jun Cao, Lei Zhang, Yajin Chen. Expression of CHODL in hepatocellular carcinoma affects invasion and migration of liver cancer cells. Oncology Letters 2017; 13(2): 715 doi: 10.3892/ol.2016.5466
|
| 5 |
Joydeep Chakraborty, Eric Hilgenfeldt, Roniel Cabrera. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 175 doi: 10.1007/978-3-319-68082-8_10
|
| 6 |
Meenakshi Gupta, Jamal Akhtar, Maryam Sarwat. MicroRNAs: Regulators of immunological reactions in hepatocellular carcinoma. Seminars in Cell & Developmental Biology 2022; 124: 127 doi: 10.1016/j.semcdb.2021.05.025
|
| 7 |
Lili Wang, Yongxiang Yi, Dandan Yin, Zhenxian Zhou, Jing Fan, Wei Ye, Wei Zhao. Augmented CD3+CD8+ and CD3+CD56− cells in cytokine-induced killer cells cultured with engineered cells for costimulatory enhancement from heavily pretreated patients with solid tumor. Cytotherapy 2016; 18(4): 581 doi: 10.1016/j.jcyt.2015.11.021
|
| 8 |
|
| 9 |
So Young Yoo, Narayanasamy Badrinath, Hyun Young Woo, Jeong Heo. Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/5198798
|
| 10 |
Leading-Edge ONCOLOGY (Vol. 20, No. 04, Full Issue). Asia-Pacific Biotech News 2016; 20(04) doi: 10.1142/S0219030316001038
|
| 11 |
Zhaoxiong Ma, Hua He, Fumou Sun, Yao Xu, Xuequn Huang, Yuexing Ma, Hong Zhao, Yang Wang, Min Wang, Juan Zhang. Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo. Journal of Cancer Research and Clinical Oncology 2017; 143(10): 1929 doi: 10.1007/s00432-017-2436-0
|
| 12 |
Shinu Chacko, Subir Samanta. “Hepatocellular carcinoma: A life-threatening disease”. Biomedicine & Pharmacotherapy 2016; 84: 1679 doi: 10.1016/j.biopha.2016.10.078
|
| 13 |
Jong Man Kim, Sung Yoo Cho, Jinsoo Rhu, Miyoung Jung, Jung Hyun Her, Okjae Lim, Gyu-Seong Choi, Eui-Cheol Shin, Yu-Kyeong Hwang, Jae-Won Joh. Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study. Annals of Hepato-Biliary-Pancreatic Surgery 2021; 25(2): 206 doi: 10.14701/ahbps.2021.25.2.206
|
| 14 |
Valerie Chew, Liyun Lai, Lu Pan, Chun Jye Lim, Juntao Li, Raymond Ong, Camillus Chua, Jing Yao Leong, Kiat Hon Lim, Han Chong Toh, Ser Yee Lee, Chung Yip Chan, Brian K. P. Goh, Alexander Chung, Pierce K. H. Chow, Salvatore Albani. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proceedings of the National Academy of Sciences 2017; 114(29) doi: 10.1073/pnas.1706559114
|
| 15 |
Ananya Ajith, Makram Merimi, Mandana Kazem Arki, Nikoo Hossein-khannazer, Mehdi Najar, Massoud Vosough, Etienne Marc Sokal, Mustapha Najimi. Immune regulation and therapeutic application of T regulatory cells in liver diseases. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1371089
|
| 16 |
YunZhen Peng, GuoJing Wu, Xin Qiu, Yue Luo, YiShu Zou, XueYan Wei, Aimin Li. Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.916024
|
| 17 |
Shanshan Wang, Anqiang Wang, Jianzhen Lin, Yuan Xie, Liangcai Wu, Hanchun Huang, Jin Bian, Xiaobo Yang, Xueshuai Wan, Haitao Zhao, Jiefu Huang. Brain metastases from hepatocellular carcinoma: recent advances and future avenues. Oncotarget 2017; 8(15): 25814 doi: 10.18632/oncotarget.15730
|
| 18 |
Alexander E Giakoustidis, Dimitrios E Giakoustidis. Immunosuppression strategies in liver transplantation patient; patients with hepatocellular carcinoma. Immunotherapy 2017; 9(2): 197 doi: 10.2217/imt-2016-0110
|
| 19 |
Vikrant Rai, Joe Abdo, Abdullah N. Alsuwaidan, Swati Agrawal, Poonam Sharma, Devendra K. Agrawal. Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma. Molecular and Cellular Biochemistry 2018; 437(1-2): 13 doi: 10.1007/s11010-017-3092-z
|
| 20 |
Dhatri Madduru, Johny Ijaq, Sujata Dhar, Saumyadip Sarkar, Naresh Poondla, Partha S. Das, Silvia Vasquez, Prashanth Suravajhala. Systems Challenges of Hepatic Carcinomas: A Review. Journal of Clinical and Experimental Hepatology 2019; 9(2): 233 doi: 10.1016/j.jceh.2018.05.002
|
| 21 |
Yawen Dong, Jeffrey Sum Lung Wong, Ryohichi Sugimura, Ka-On Lam, Bryan Li, Gerry Gin Wai Kwok, Roland Leung, Joanne Wing Yan Chiu, Tan To Cheung, Thomas Yau. Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC. Cancers 2021; 13(8): 1949 doi: 10.3390/cancers13081949
|
| 22 |
Vito Longo, Antonio Gnoni, Andrea Casadei Gardini, Salvatore Pisconti, Antonella Licchetta, Mario Scartozzi, Riccardo Memeo, Vincenzo Ostilio Palmieri, Giuseppe Aprile, Daniele Santini, Patrizia Nardulli, Nicola Silvestris, Oronzo Brunetti. Immunotherapeutic approaches for hepatocellular carcinoma. Oncotarget 2017; 8(20): 33897 doi: 10.18632/oncotarget.15406
|
| 23 |
Dan Lv, Li-hong Pan, Ren Zhang, Jie Yang, Hao Chen, Yanzhang Wen, Mi Huang, Xinhua Ma, Qiang Wang, Xinzhou Yang. Essential oil from Euphorbia esula inhibits proliferation and induces apoptosis in HepG2 cells via mitochondrial dysfunction. Brazilian Journal of Pharmaceutical Sciences 2020; 56 doi: 10.1590/s2175-97902019000317542
|
| 24 |
Marco Puzzoni, Nicola Silvestris, Francesco Leone, Riccardo Giampieri, Luca Faloppi, Laura Demurtas, Emanuela Dell’Aquila, Donatella Marino, Oronzo Brunetti, Silvio Ken Garattini, Elena Ongaro, Giorgio Astara, Laura Orgiano, Giuseppe Aprile, Daniele Santini, Mario Scartozzi. The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?. Targeted Oncology 2016; 11(5): 593 doi: 10.1007/s11523-016-0437-6
|
| 25 |
Bingling Dai, Xianpeng Shi, Nan Ma, Weina Ma, Yanmin Zhang, Tianfeng Yang, Jie Zhang, Langchong He. HMQ‐T‐B10 induces human liver cell apoptosis by competitively targeting EphrinB2 and regulating its pathway. Journal of Cellular and Molecular Medicine 2018; 22(11): 5231 doi: 10.1111/jcmm.13729
|
| 26 |
Thaweesak Chieochansin, Chutamas Thepmalee, Janya Grainok, Mutita Junking, Pa-thai Yenchitsomanus. Cytolytic Activity of Effector T-lymphocytes Against Hepatocellular Carcinoma is Improved by Dendritic Cells Pulsed with Pooled Tumor Antigens. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-54087-0
|
| 27 |
Min Ding, Ying Wang, Jiachang Chi, Tao Wang, Xiaoyin Tang, Dan Cui, Qijun Qian, Bo Zhai, Beicheng Sun. Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients. PLOS ONE 2016; 11(12): e0168798 doi: 10.1371/journal.pone.0168798
|
| 28 |
Jie Shen, Li-Feng Wang, Zheng-Yun Zou, Wei-Wei Kong, Jing Yan, Fan-Yan Meng, Fang-Jun Chen, Juan Du, Jie Shao, Qiu-Ping Xu, Hao-Zhen Ren, Ru-Tian Li, Jia Wei, Xiao-Ping Qian, Bao-Rui Liu. Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(29): 5395-5404 doi: 10.3748/wjg.v23.i29.5395
|
| 29 |
Yu-Lan Li, Xiao-Min Zhu, Hong Liang, Chris Orvig, Zhen-Feng Chen. Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery. Current Medicinal Chemistry 2021; 28(8): 1508 doi: 10.2174/0929867327666200505085756
|